In the central nervous system, some specific phosphodiesterase (PDE) isoforms modulate pathways involved in neuronal plasticity. Accumulating evidence suggests that PDE9 may …
NK Singh, P Singh, P Varshney… - … of Biochemical and …, 2024 - Wiley Online Library
Abstract Phosphodiesterase type 5 (PDE5) is an enzyme primarily found in the smooth muscle of the corpus cavernosum and also highly expressed in the substantia nigra …
HE Yelkenci, Z Degirmenci, HI Koc, S Bayirli… - Molecular …, 2024 - Springer
Traumatic brain injury (TBI), also known as intracranial injury, is a common condition with the highest incidence rate among neurodegenerative disorders and poses a significant …
Introduction: Memory dysfunction has remained a challenging issue globally. Nootropics have proven fruitful in managing cognitive dysfunction but because of their side effects …
A Bagán, A López-Ruiz, S Abás… - Journal of medicinal …, 2025 - ACS Publications
Imidazoline I 2 receptors (I2-IRs) are altered in Alzheimer's disease (AD) patients and are associated with analgesia. I2-IRs are not structurally described, and their pharmacological …
Background Innate immune stimulants, including mycobacterium cell wall fractions (MCWF), offer an alternative control option to prevent and treat disease in livestock, by appropriately …
Human cognition fundamentally depends on memory. Alzheimer's disease exhibits a strong correlation with a decline in this factor. Phosphodiesterase‐4 B (PDE4B) plays a crucial role …
J Rong, T Yamasaki, J Chen, K Kumata, C Zhao… - ACS …, 2024 - ACS Publications
Phosphodiesterases (PDEs) constitute a superfamily of phosphohydrolytic enzymes that regulate intracellular second messenger signaling by hydrolyzing cyclic adenosine …